InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-9.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Valeriani Nicholas J, 董事. Director active across 2 companies, notably Edwards Lifesciences Corp. In total, 10 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €194k. Activity tracked since 5 May 2021. The latest transaction was disclosed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Valeriani Nicholas J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
5,564 股0Common StockSEC:0001225208-25-004956:0
4,818 股0Common StockSEC:0001225208-24-005897:0
2,803 股0Common StockSEC:0001225208-23-005911:0
22,857 股0Common StockSEC:0001209191-22-046170:0
2,300 股0Common StockSEC:0001225208-22-006588:0
1,500 股@ US$112.23100.0% 占其流量Common StockSEC:0001225208-21-014149:0
标准退出：2022年2月22日 (T+90)
55,000 股@ US$0.95100.0% 占其流量Common StockSEC:0001209191-21-051328:0
标准退出：2021年11月10日 (T+90)
72,254 股0Common StockSEC:0001209191-21-045041:0
57,803 股0Common StockSEC:0001209191-21-031342:0
2,615 股0Common StockSEC:0001225208-21-007760:0
10 条申报中的 10 条
About Valeriani Nicholas J
Nicholas J. Valeriani is a Board Member at Edwards Lifesciences Corp and Surgalign Holdings, Inc. In this role, he contributes to the governance of these companies, bringing his expertise to the board. Edwards Lifesciences is a leader in medical technologies, while Surgalign focuses on surgical solutions. Mr. Valeriani's experience in these sectors is valuable for guiding strategic decisions.
